The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Can You Take Mounjaro If You Don't Have a Gallbladder?
If you've had your gallbladder removed (cholecystectomy) and are considering Mounjaro for weight management, you may wonder whether this GLP-1 medication is still safe for you. The straightforward answer is that having no gallbladder doesn't automatically disqualify you from Mounjaro or Wegovy, but your prescriber needs to know this during your clinical assessment. Both medications can affect digestion and bile flow, so individual suitability requires professional evaluation. This guide explains what you need to know about taking prescription weight loss injections after gallbladder removal.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro, Wegovy, and Gallbladder Health — Clinical Considerations
Mounjaro (tirzepatide) is a prescription-only, once-weekly injectable medication that works as a dual GIP and GLP-1 receptor agonist. Wegovy (semaglutide) is a once-weekly GLP-1 agonist. Both can slow gastric emptying—how quickly food moves through your stomach—which affects bile production and digestion. If you've had a cholecystectomy, your body has already adapted to digest fats without a gallbladder by releasing bile continuously from the liver rather than in concentrated amounts. However, GLP-1 medications may further slow this process, potentially causing digestive discomfort.
In clinical trials: SURMOUNT-1 (Mounjaro) showed average weight loss of 20.9% at the maximum 15mg dose, whilst STEP-1 (Wegovy) showed clinically studied weight loss on the 2.4mg dose. Neither trial specifically excluded people without gallbladders, but post-cholecystectomy patients were likely under-represented. Your prescriber needs to assess whether either medication is right for you individually, using your full medical history.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
What Your Prescriber Will Consider
Before prescribing Mounjaro or Wegovy, your clinician will review your complete health profile, including previous gallbladder removal and any ongoing digestive symptoms. If you experience persistent diarrhoea, fatty stool (steatorrhoea), or abdominal discomfort after cholecystectomy, this information is crucial. Some people report improved digestion on GLP-1 medications because reduced appetite and slower eating can ease post-cholecystectomy symptoms; others may experience worsening nausea or constipation.
Your prescriber may recommend starting at a lower dose and increasing gradually to monitor how your body responds. You should also use our free GLP-1 weight loss calculator to explore expected outcomes at different doses, and our BMI calculator to establish your baseline health metrics before beginning treatment. Always inform your GP or prescriber about your cholecystectomy and any related digestive issues.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro safe if I don't have a gallbladder?
Mounjaro is not automatically unsafe without a gallbladder, but your prescriber must know about your cholecystectomy during your clinical assessment. GLP-1 medications affect digestion and bile flow, so individual suitability varies. Your GP or prescriber will evaluate your specific circumstances and any ongoing digestive symptoms before deciding whether Mounjaro is appropriate for you.
How does Mounjaro differ from Wegovy in terms of gallbladder health?
Mounjaro is a dual GIP and GLP-1 agonist, whilst Wegovy is a GLP-1 agonist only. Both slow gastric emptying and can affect digestion. There is no clinical evidence that one is safer than the other for post-cholecystectomy patients. Your prescriber will base their choice on your overall health profile, weight loss goals, and how your body typically responds to medication.
What symptoms should I watch for if I take Mounjaro without a gallbladder?
Common Mounjaro side effects include nausea, diarrhoea, constipation, and abdominal pain. If you've had your gallbladder removed, watch for worsening fatty stools, persistent diarrhoea, or abdominal discomfort that differs from your normal post-surgery digestion pattern. Report any concerning changes to your GP immediately, especially severe stomach pain.
Can I switch from Mounjaro to Wegovy if I develop gallbladder-related side effects?
Switching medications is possible, but only under prescriber guidance. Both Mounjaro and Wegovy affect digestion similarly, so switching alone may not solve gallbladder-related issues. Your prescriber might adjust your dose, recommend dietary changes, or explore whether the medication is suitable long-term. Never stop or switch medications without professional advice.
Should I mention my cholecystectomy when I apply for Mounjaro?
Yes, absolutely. When you apply for Mounjaro or Wegovy through an online clinical assessment, you must disclose that you've had your gallbladder removed. This is essential information for the prescriber to assess your eligibility. Failing to mention it could lead to inappropriate prescribing and preventable side effects.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.